Journals / Tüberküloz ve Toraks / 2002 / Cilt: 50 - Sayı: 1

Sklerodermada pulmoner hemodinami, arteryal kan gazları ve solunum testleri arasındaki ilişki

The relationship between pulmonary hemodynamics, arterial blood gases and ventilatory tests in scleroderma

Pages
5–11
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Derangement of pulmonary functions and arterial desaturation is common during the course of the disease.The aim of this study was to investigate the relationship between pulmonary hemodynamics, pulmonary function tests and arterial blood gases in 13 patients with scleroderma.All patients were female with age ranging between 27-64 years.Except for two patients, all had Raynaud' s phenomenon.The analysis of mean pulmonary artery pressure showed mild pulmonary hypertension.There was a significant negative correlation between the mean pulmonary artery pressure and the Pa$O_2$ (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Scleroderma is a disorder characterized by skin, gastrointestinal tractus, cardiac, pulmonary, renal and muscular involvement with unknown etiology.
📊
Key Findings & Data:Raynaud' s phenomenon is a frequent finding in the early stages.Pulmonary hypertension may be observed in 33-60% of the patients.
💡
Conclusion & Impact:Derangement of pulmonary functions and arterial desaturation is common during the course of the disease.The aim of this study was to investigate the relationship between pulmonary hemodynamics, pulmonary function tests and arterial blood gases in 13 patients with scleroderma.All patients were female with age ranging between 27-64 years.Except for two patients, all had Raynaud' s phenomenon.The analysis of mean pulmonary artery pressure showed mild pulmonary hypertension.There was a significant negative correlation between the mean pulmonary artery pressure and the Pa$O_2$ (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Scleroderma is a disorder characterized by skin, gastrointestinal tractus, cardiac, pulmonary, renal and muscular involvement with unknown etiology. Raynaud' s phenomenon is a frequent finding in the early stages.Pulmonary hypertension may be observed in 33-60% of the patients. Derangement of pulmonary functions and arterial desaturation is common during the course of the disease.The aim of this study was to investigate the relationship between pulmonary hemodynamics, pulmonary function tests and arterial blood gases in 13 patients with scleroderma.All patients were female with age ranging between 27-64 years.Except for two patients, all had Raynaud' s phenomenon.The analysis of mean pulmonary artery pressure showed mild pulmonary hypertension.There was a significant negative correlation between the mean pulmonary artery pressure and the Pa$O_2$ (p

Özet

Skleroderma etyolojisi bilinmeyen, cilt, gastrointestinal sistem, kalp, akciğerler, böbrek ve kasları tutan bir hastalıktır. Raynaud' s fenomeni erken evrelerde sık görülen bir bulgudur.Pulmoner hipertansiyon olguların %33-60 ' ında görülmektedir.Hastalığın seyrinde solunum fonksiyonlarında azalma ve arteryel desatürasyon sık görülür.Bu çalışmadaki amacımız;sklerodermalı 13 olguda pulmoner hemodinami, solunum fonksiyonları ve arter kan gazları arasındaki ilişkiyi araştırmaktı.Bütün olgular kadındı ve yaşları 27-64 yaşları arasında değişiyordu.İki olgu dışında hepsinde Raynaud' s fenomeni bulunuyordu. Ortalama pulmoner arter basınç değerine göre hafif şiddetli pulmoner hipertansiyon tespit edildi.Ortalama pulmoner arter basıncı ile Pa$O_2$ arasında anlamlı negatif korelasyon vardı (p< 0.05)Olgularımızda difüzyon kapasitesinde azalma ile birlikte restiktif ventilatuvar defekt gözlendi.Sonuç olarak;kötü prognoz göstergesi olan pulmoner hipertansiyon, sklerodermanın sıklıkla görülen bir komplikasyonudur.Hipoksemi ve pulmoner fibrozis ile koreledir.

🔖

Cite This Article

DÜZGÜN, N., KARABIYIKOĞLU, G., SARYAL, S., AKKOCA, Ö. (2022). Sklerodermada pulmoner hemodinami, arteryal kan gazları ve solunum testleri arasındaki ilişki. Tüberküloz ve Toraks, Cilt: 50 - Sayı: 1, 5–11. https://ajindex.com/articles/619352

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Bryan C, Knight C, Black CM, Silman AJ. Prediction of fiver-year survival following presentation with scleroderma. Arthritis & Rheumatism 1999
  2. Owens GR, Follansbee WP. Cardiopulmonary manifestations of systemic sclerosis. Chest 1987
  3. Steen VD, Owens GR, Fino GJ, et al. Pulmonary involvement in systemic sclerosis (scleroderma). Arthritis & Rheumatism 1985
  4. Trell E, Lindström C. Pulmonary hypertension in systemic sclerosis. Ann Rheum Dis 1971
  5. Ungerer RG, Tashkin DP, Furst D, et al. Prevalence and clinical correlates of pulmonary arterial hypertension in progressive systemic sclerosis. Am J Med 1983
  6. Tashkin DP, Clements PJ, Wright RS, et al. Interrelationship between pulmonary and extrapulmonary involvement in systemic sclerosis. Chest 1994
  7. 4S9-95. 7.Lee P, Langevitz P, Alderdice CA, et al. Mortality in systemic sclerosis (scleroderma). Quarterly J Med 1992
  8. Peters-Golden M, Wise RA, Hochberg MC, et al. Carbon-monoxide diffusing capacity as predictor of outcome in systemic sclerosis. Am J Med 1984
  9. Kory RC, Callahan R, Baren HG, Syner JC. The veterans administration army cooperative study of pulmonary functions l. clinical spirometry in normal man. Am J Med 1961
  10. Çelik G, Karabıyıkoğlu G. Local and peripheral plasma endothelin-1 in pulmonary hypertension secondary to chronic obstructive pulmonary disease. Respiration 1998
  11. Battle RW, Davitt MA, Cooper SM, et al. Prevalence of pulmonary hypertension in limited and diffuse scleroderma. Chest 1996
  12. Stupi AM, Steen VD, Owens GR, et al. Pulmonary hypertension in the chest syndrome variant of systemic sclerosis. Arthritis & Rheumatism 1986
  13. Murata I, Takenaka K, Yoshinoya S, et al. Clinical evaluation of pulmonary hypertension in systemic sclerosis and related disorders. Chest 1997
  14. Salerni R, Rodnan GP, Leon DF, et al. Pulmonary hypertension in the CREST syndrome variant of progressiue systemic sclerosis (scleroderma). Ann Inter Med 1977
  15. Morgan JM, Griffiths M, Bois RM, Evans TW.Hypoxic pulmonary vasoconstriction in systemic sclerosis and primary pulmonary hypertension. Chest 1991
  16. Sfikalis PP, Kyriakidis M, Vergos C, et al. Diffusing capacity of the lung and nifedipine in systemic sclerosis. Arthritis-Rheumatism 1990
  17. Laitinen O, Salorinne V, Poppius H. Respiratory function in systemic lup